These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 22171785)

  • 1. HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef.
    Sauter D; Hué S; Petit SJ; Plantier JC; Towers GJ; Kirchhoff F; Gupta RK
    Retrovirology; 2011 Dec; 8():103. PubMed ID: 22171785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of adaptation to human tetherin in HIV-1 group O and P.
    Yang SJ; Lopez LA; Exline CM; Haworth KG; Cannon PM
    Retrovirology; 2011 Sep; 8():78. PubMed ID: 21955466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2.
    Jia B; Serra-Moreno R; Neidermyer W; Rahmberg A; Mackey J; Fofana IB; Johnson WE; Westmoreland S; Evans DT
    PLoS Pathog; 2009 May; 5(5):e1000429. PubMed ID: 19436700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2.
    Heusinger E; Deppe K; Sette P; Krapp C; Kmiec D; Kluge SF; Marx PA; Apetrei C; Kirchhoff F; Sauter D
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient Vpu-Mediated Tetherin Antagonism by an HIV-1 Group O Strain.
    Mack K; Starz K; Sauter D; Langer S; Bibollet-Ruche F; Learn GH; Stürzel CM; Leoz M; Plantier JC; Geyer M; Hahn BH; Kirchhoff F
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptation of human and simian immunodeficiency viruses for resistance to tetherin/BST-2.
    Serra-Moreno R; Evans DT
    Curr HIV Res; 2012 Jun; 10(4):277-82. PubMed ID: 22524175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vpu of a Simian Immunodeficiency Virus Isolated from Greater Spot-Nosed Monkey Antagonizes Human BST-2 via Two AxxxxxxxW Motifs.
    Yao W; Yoshida T; Hashimoto S; Takeuchi H; Strebel K; Yamaoka S
    J Virol; 2020 Jan; 94(2):. PubMed ID: 31666374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance.
    Kmiec D; Iyer SS; Stürzel CM; Sauter D; Hahn BH; Kirchhoff F
    mBio; 2016 Aug; 7(4):. PubMed ID: 27531907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the human immunodeficiency virus type 1 M group Vpu domains involved in antagonizing tetherin.
    Petit SJ; Blondeau C; Towers GJ
    J Gen Virol; 2011 Dec; 92(Pt 12):2937-2948. PubMed ID: 21900423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transmembrane domain of HIV-1 Vpu is sufficient to confer anti-tetherin activity to SIVcpz and SIVgor Vpu proteins: cytoplasmic determinants of Vpu function.
    Kluge SF; Sauter D; Vogl M; Peeters M; Li Y; Bibollet-Ruche F; Hahn BH; Kirchhoff F
    Retrovirology; 2013 Mar; 10():32. PubMed ID: 23514615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ancient adaptive evolution of tetherin shaped the functions of Vpu and Nef in human immunodeficiency virus and primate lentiviruses.
    Lim ES; Malik HS; Emerman M
    J Virol; 2010 Jul; 84(14):7124-34. PubMed ID: 20444900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. βTrCP is Required for HIV-1 Vpu Modulation of CD4, GaLV Env, and BST-2/Tetherin.
    Song YE; Cyburt D; Lucas TM; Gregory DA; Lyddon TD; Johnson MC
    Viruses; 2018 Oct; 10(10):. PubMed ID: 30347660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nef proteins of epidemic HIV-1 group O strains antagonize human tetherin.
    Kluge SF; Mack K; Iyer SS; Pujol FM; Heigele A; Learn GH; Usmani SM; Sauter D; Joas S; Hotter D; Bibollet-Ruche F; Plenderleith LJ; Peeters M; Geyer M; Sharp PM; Fackler OT; Hahn BH; Kirchhoff F
    Cell Host Microbe; 2014 Nov; 16(5):639-50. PubMed ID: 25525794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetherin/BST-2: Restriction Factor or Immunomodulator?
    Li SX; Barrett BS; Guo K; Santiago ML
    Curr HIV Res; 2016; 14(3):235-46. PubMed ID: 26957198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Counteraction of tetherin antiviral activity by two closely related SIVs differing by the presence of a Vpu gene.
    Nikovics K; Dazza MC; Ekwalanga M; Mammano F; Clavel F; Saragosti S
    PLoS One; 2012; 7(4):e35411. PubMed ID: 22530020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains.
    Sauter D; Schindler M; Specht A; Landford WN; Münch J; Kim KA; Votteler J; Schubert U; Bibollet-Ruche F; Keele BF; Takehisa J; Ogando Y; Ochsenbauer C; Kappes JC; Ayouba A; Peeters M; Learn GH; Shaw G; Sharp PM; Bieniasz P; Hahn BH; Hatziioannou T; Kirchhoff F
    Cell Host Microbe; 2009 Nov; 6(5):409-21. PubMed ID: 19917496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Vpu Antagonizes CD317/Tetherin by Adaptor Protein-1-Mediated Exclusion from Virus Assembly Sites.
    Pujol FM; Laketa V; Schmidt F; Mukenhirn M; Müller B; Boulant S; Grimm D; Keppler OT; Fackler OT
    J Virol; 2016 Aug; 90(15):6709-6723. PubMed ID: 27170757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetherin/BST-2 antagonism by Nef depends on a direct physical interaction between Nef and tetherin, and on clathrin-mediated endocytosis.
    Serra-Moreno R; Zimmermann K; Stern LJ; Evans DT
    PLoS Pathog; 2013; 9(7):e1003487. PubMed ID: 23853598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cytoplasmic tail determinant in HIV-1 Vpu mediates targeting of tetherin for endosomal degradation and counteracts interferon-induced restriction.
    Kueck T; Neil SJ
    PLoS Pathog; 2012; 8(3):e1002609. PubMed ID: 22479182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human tetherin exerts strong selection pressure on the HIV-1 group N Vpu protein.
    Sauter D; Unterweger D; Vogl M; Usmani SM; Heigele A; Kluge SF; Hermkes E; Moll M; Barker E; Peeters M; Learn GH; Bibollet-Ruche F; Fritz JV; Fackler OT; Hahn BH; Kirchhoff F
    PLoS Pathog; 2012 Dec; 8(12):e1003093. PubMed ID: 23308067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.